Chutes & Ladders—Celgene brings on Keytruda R&D executive in shake-up
Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please send the good word—or the bad—from your shop to Conor Hale, and we will feature it here at the end of each week.
CelgeneAlise Reicin,M.D.,was named president of global clinical development.
Reicin, who has worked for both Mercks—German and U.S.—including on the latter's Keytruda, will take over leadership of Celgene's mid- to late-stage drug development portf...